Sinovac Biotech Price to Book Ratio 2006-2020 | SVA

Historical price to book ratio values for Sinovac Biotech (SVA) over the last 10 years. The current price to book ratio for Sinovac Biotech as of October 22, 2021 is 0.57.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Sinovac Biotech Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2019-02-22 6.47 inf
2018-06-30 7.46 0.00
2018-03-31 8.61 0.00
2016-12-31 5.90 $2.27 2.59
2016-09-30 5.90 0.00
2016-06-30 5.93 0.00
2016-03-31 6.39 0.00
2015-12-31 5.72 $2.40 2.38
2015-09-30 5.08 0.00
2015-06-30 5.25 0.00
2015-03-31 4.96 0.00
2014-12-31 5.23 $2.54 2.06
2014-09-30 4.81 0.00
2014-06-30 5.64 0.00
2014-03-31 7.20 0.00
2013-12-31 6.12 0.00
2013-09-30 5.98 0.00
2013-06-30 3.93 0.00
2013-03-31 3.72 0.00
2012-12-31 3.14 0.00
2012-09-30 2.52 0.00
2012-06-30 2.11 0.00
2012-03-31 2.04 0.00
2011-12-31 2.20 0.00
2011-09-30 2.23 0.00
2011-06-30 3.20 0.00
2011-03-31 4.53 0.00
2010-12-31 4.52 0.00
2010-09-30 3.90 0.00
2010-06-30 4.63 0.00
2010-03-31 5.91 0.00
2009-12-31 6.33 0.00
2009-09-30 8.29 0.00
2009-06-30 3.95 0.00
2009-03-31 1.46 0.00
2008-12-31 1.38 0.00
2008-09-30 2.50 0.00
2008-06-30 3.25 0.00
2008-03-31 3.64 0.00
2007-12-31 5.12 0.00
2007-09-30 5.45 0.00
2006-12-31 2.32 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.642B $0.511B
Sonovac Biotech Ltd. specializes in the research, development, commercialization, and sales of human vaccines for infectious illnesses such as hepatitis A and hepatitis B, influenza, `SARS`, and avian flu. Sinovac is one of the leading emerging biotechnology companies in China.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76